Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of human embryonic stem cells for drug screening and toxicity testing

Use of human embryonic stem cells for drug screening and toxicity testing

US Patent 7041438 · Granted May 9, 2006

Estimated economic value: $5,055,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Base station2025
Oximetry probe and method of operating the same, and oximetry sensor2024
Dried dye reagent devices and methods for making and using the same2022
Dual mode microendoscope concentrating light emission into ring area2021
Methods and compositions for obtaining a tuberculosis assessment in a subject2020
Methods of measuring cell purity for making quality control determinations and r2019
Neural cell populations from primate pluripotent stem cells2019
Screening methods for human embryonic stem cells2018
Screening methods for human embryonic stem cells2018
Neural progenitor cell populations2017
Neural cell populations from primate pluripotent stem cells2017
Protocols for making hepatocytes from embryonic stem cells2017